OP ED by Dr Joeseph Mercola: CDC Now Lists Some Vaccinated Deaths as Unvaccinated cities929.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cities929.com Daily Mail and Mail on Sunday newspapers.
AP Photo/Elaine Thompson
Last week the CDC issued a notification titled “Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing” via its Laboratory Outreach Communication System regarding COVID-19 testing and managed to confuse everyone in the process. In the statement, CDC reported that they were withdrawing their Emergency Use Authorization (EUA) request to the FDA for their CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel, and suggested anyone using this test switch to one of the many viable and FDA-approved alternatives. In short, there are a number of tests out on the market now with FDA authorization, and there really is no need to continue the application for this one particular test developed by the CDC.
Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV dovepress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dovepress.com Daily Mail and Mail on Sunday newspapers.
Industry News: LGC’s ValuPanel Reagents help public laboratories detect SARS-CoV-2 and influenza
Each line of ValuPanel Reagents consists of separately delivered probes and primers, which allow assay flexibility and sizes that can help facilitate scale-up
26 Apr 2021
LGC, Biosearch Technologies has announced the release of a new set of ValuPanel™ Reagents to help the efforts of public health laboratories to detect SARS-CoV-2, influenza A, and influenza B.
The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex ValuPanel Reagents - which are for research use only and not for use in diagnostic procedures - consists of probes and primers for multiplex RT-PCR detection and allows discrimination of SARS-CoV-2, influenza A, and influenza B from a single patient sample.